USPTO trademark

Travere Therapeutics, Inc design mark 6672523

RegisteredUSPTOFigurative markClass 42

"Design mark 6672523" is a figurative mark owned by Travere Therapeutics, Inc., filed at the USPTO on February 15, 2019. It is registered and covers class 42 (Computer and Scientific Services).

Official USPTO record
Travere Therapeutics, Inc design mark 6672523 trademark as filed
As filed with the USPTO
Status
Registered
Since March 15, 2022
Filed
February 15, 2019
Registered
March 15, 2022
Expires
Not recorded
Application no.
88304150
Registration no.
6672523
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Travere Therapeutics, Inc design mark 6672523

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services Travere Therapeutics, Inc design mark 6672523 is filed for, grouped by Nice class.

  • Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Registered-principal register
  2. Notice of acceptance of statement of use e-mailed
  3. Allowed principal register - sou accepted
  4. Statement of use processing complete
  5. Case assigned to intent to use paralegal
  6. Use amendment filed
  7. Teas statement of use received
  8. Notice of approval of extension request e-mailed
  9. Sou extension 4 granted
  10. Sou extension 4 filed

10 earlier steps on the official record.

FAQ

About Travere Therapeutics, Inc design mark 6672523

Who owns the trademark "Design mark 6672523"?

The USPTO trademark "Design mark 6672523" (application 88304150) is owned by Travere Therapeutics, Inc.

What is the status of "Design mark 6672523"?

Its status at the USPTO is: registered.

When was "Design mark 6672523" registered?

It was registered on March 15, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Travere Therapeutics, Inc design mark 6672523 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2a40-670b-741a-b31e-a9310fb42534
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a40-670b-741a-b31e-a9310fb42534",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88304150",
  "filing_date": "2019-02-15",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "TRAVERE THERAPEUTICS, INC.",
      "entity_id": "ent_019eb707-34f4-74c3-97ba-bc365debc736"
    }
  ]
}